# C_2022025EN.01002101.xml

| 18.1.2022 | EN | Official Journal of the European Union | C 25/21 |
| --- | --- | --- | --- |

18.1.2022

EN

Official Journal of the European Union

C 25/21

---

Prior notification of a concentration

(Case M.10590 – PAI PARTNERS / OTPP / VEONET)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 25/05)

1.

This notification concerns the following undertakings:

| — | PAI Partners Sàrl (‘PAI Partners’, France), controlled by PAI Partners SAS; |
| --- | --- |

—

PAI Partners Sàrl (‘PAI Partners’, France), controlled by PAI Partners SAS;

| — | Ontario Teachers’ Pension Plan Board (‘OTPP’, Canada); and, |
| --- | --- |

—

Ontario Teachers’ Pension Plan Board (‘OTPP’, Canada); and,

| — | Veonet GmbH and all of its direct and indirect subsidiaries (‘Veonet Group’, Germany) |
| --- | --- |

—

Veonet GmbH and all of its direct and indirect subsidiaries (‘Veonet Group’, Germany)

PAI Partners and OTPP acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation indirect joint control of Veonet Group.

The concentration is accomplished by way of purchase of shares.

2.

| — | for PAI Partners: private equity firm, managing a number of funds investing in the business services, food & consumer, general industrials, and healthcare sectors, |
| --- | --- |

—

for PAI Partners: private equity firm, managing a number of funds investing in the business services, food & consumer, general industrials, and healthcare sectors,

| — | for OTPP: corporation administering pension benefits and the investment of pension plan assets on behalf of active and retired teachers in Ontario, |
| --- | --- |

—

for OTPP: corporation administering pension benefits and the investment of pension plan assets on behalf of active and retired teachers in Ontario,

| — | for Veonet Group: clinic network of ophthalmological care and outpatient treatment for major causes of blindness and visual impairment, offering diagnosis as well as surgical and non-invasive treatment of eye disorders. |
| --- | --- |

—

for Veonet Group: clinic network of ophthalmological care and outpatient treatment for major causes of blindness and visual impairment, offering diagnosis as well as surgical and non-invasive treatment of eye disorders.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10590 – PAI PARTNERS / OTPP / VEONET

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  
  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  
  OJ C 366, 14.12.2013, p. 5.

2

---